Last year, DeepMind announced a solution to the huge challenge of protein folding with itsAI system AlphaFold2, capable of predicting the 3D structure of a protein directly from its amino acid sequence to atomic-level accuracy. The algorithm could help replace or enhance hard laboratory work to identify the structures of proteins, which indicates their behaviour.
π± Novartis launched the Evidence Lab: a platform to pressure-test and validate digital health solutions with healthcare systems, healthcare professionals and patients β to match proven solutions to health challenges.
π Why health remains a blind spot for investors. A recent report from ShareAction finds a gap between public perceptions on health and investorsβ actions. Investors do not have the necessary support or inclination to implement effective screening measures.
πΌ We're hiring! If you are interested in delivering industry-leading research (or working in product, sales or marketing), check out our jobs page.
πΊπΈ Platelet BioGenesis, the only allogeneic cell therapy company focused on platelet biology, raised $75.5M in Series B.
π¬π§Gyroscope Therapeutics, another University of Cambridge spinout, developing gene therapies for retinal diseases raised $60M in Series C from Sanofi.
Other notable deals from around the globe:
πΊπΈ LightForce Orthodontics, manufacturer of customized 3D-printed bracket systems, raised $50M in Series C to scale operations and go-to-market.
This is Dealroom's weekly health newsletter. You can subscribe here to get more industry-specific intelligence on the evolving world of healthtech and biotech, emerging trends, and game-changing startups. Delivered on Thursdays.
Dealroom.co, Cornelis Dirkszstraat 27-2, 1056 TP, Amsterdam, The Netherlands